Insulet (PODD) has been on a downward spiral lately with significant selling pressure. After declining 17.3% over the past ...

(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...

Insulet Corporation (NASDAQ:PODD) is one of the most oversold healthcare stocks to invest in. Insulet Corporation (NASDAQ:PODD) received a rating update from Truist on April 15. The firm cut the price ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin ...

To Read the Recap, Click Here. PODD convened 1,000 senior drug delivery executives from pharmaceutical, biotech, medical device, and across all areas of drug delivery focused on developing more ...

The PODD: Partnership Opportunities in Drug Delivery conference announced the keynotes for its 15th annual conference which takes place on October 27-28 at the Westin Copley Place in Boston, MA. “In ...

Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains for ...